top of page
Home
All News
Pharma
APAC
Brazil
Canada Pharma
China Pharma
Europe Pharma
India Pharma
Japan Pharma
North America
Saudi Arabia
US FDA Approvals
Therapy News
Immunology
Neurology
Oncology
Kidney Diseases
Cardiovascular
Infections_Vaccines
Metabolic Diseases
Women Health
Healthcare News
US Healthcare News
US Payer News
Europe Healthcare News
Germany Healthcare
Italy
United Kingdom Healthcare
APAC - Healthcare News
Brazil Healthcare
Healthcare Policies
Conferences
About
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
US_PayerNews
Radioligand therapy
NICE recommendations
Germany Healthcare Pharma News
HAS Assessment Outcomes
Neurology
Immunology
Blood Disorders
Oncology
Kidney Diseases
Cardiovascular Diseases
Infectious_Vaccines
Search
Eli Lilly to acquire Ventyx Biosciences; will significantly strengthen immunology and neurology portfolio | iPharmaCenter
ipharmaservices
Jan 8
Johnson & Johnson Secures European Commission Approval for IMAAVY (Nipocalimab) to Treat Generalised Myasthenia Gravis
Badari Andukuri
Dec 5, 2025
Bristol Myers Squibb Extends Cobenfy Trial in Alzheimer’s Psychosis After DMC Recommendation | iPharmaCenter
Badari Andukuri
Dec 3, 2025
Migraine News | Updates | Atogepant | iPharmaCenter
ipharmaservices
Aug 20, 2023
Spinal Muscular Atrophy News | Zolgensma | Evrysdi | Spinraza | iPharmaCenter
ipharmaservices
Aug 13, 2023
Alzheimer’s disease News | CHMP says no to Aduhelm | Biogen slashed the price of Aduhelm
ipharmaservices
Feb 28, 2023
Epilepsy News | Updates | iPharmaCenter
ipharmaservices
Oct 17, 2022
Neuromyelitis optica spectrum disorder | news | blogs | iPharmaCenter
ipharmaservices
Oct 13, 2022
bottom of page
